M&A Deal Summary |
|
|---|---|
| Date | 2017-02-16 |
| Target | Talent Biotechs |
| Sector | Life Science |
| Buyer(s) | Claritas Pharmaceuticals |
| Deal Type | Add-on Acquisition |
| Deal Value | 10M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2014 |
| Sector | Life Science |
Claritas Pharmaceuticals is a developer of proprietary cannabidiol (“CBD”) therapeutics. CBD is a remarkable compound that has shown activity against a number of pharmacological targets. Claritas Pharmaceuticals was founded in 2014 and is headquartered in San Rafael, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science M&A | 1 of 2 |
| Type: Add-on Acquisition M&A Deals | 1 of 2 |
| Country: Israel M&A | 1 of 1 |
| Year: 2017 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-05-19 |
Salzman Group
West Tisbury, Massachusetts, United States Salzman Group, Inc. is a global drug development company that seeks to transform medical practice by undertaking transformative pharmaceutical innovation. As an organization, Salzman Group prides itself on a high-energy culture of accountability, teamwork, and creativity. Salzman Group was formed in 1996 and is based in West Tisbury, Massachusetts. |
Buy | - |
